

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sphingosine metabolic process (GO:0006670) | 9.01144758 |
| 2 | diol metabolic process (GO:0034311) | 7.98340287 |
| 3 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 7.32972107 |
| 4 | sphingoid metabolic process (GO:0046519) | 7.25142183 |
| 5 | protein-chromophore linkage (GO:0018298) | 5.61285591 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.32146859 |
| 7 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 5.28914464 |
| 8 | regulation of meiosis I (GO:0060631) | 5.25773454 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.24696295 |
| 10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.18778754 |
| 11 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.08674110 |
| 12 | paraxial mesoderm development (GO:0048339) | 5.01997728 |
| 13 | regulation of pigment cell differentiation (GO:0050932) | 4.99005511 |
| 14 | positive regulation of meiosis (GO:0045836) | 4.93409207 |
| 15 | DNA methylation involved in gamete generation (GO:0043046) | 4.92424948 |
| 16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.88509201 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 4.87651290 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.85353695 |
| 19 | notochord development (GO:0030903) | 4.84261063 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.76663381 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.73163086 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.62946881 |
| 23 | cell communication involved in cardiac conduction (GO:0086065) | 4.55790342 |
| 24 | positive regulation of meiotic cell cycle (GO:0051446) | 4.55452388 |
| 25 | respiratory electron transport chain (GO:0022904) | 4.54286720 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 4.49904289 |
| 27 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.49886470 |
| 28 | electron transport chain (GO:0022900) | 4.44096229 |
| 29 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.42333157 |
| 30 | lipopolysaccharide biosynthetic process (GO:0009103) | 4.37473306 |
| 31 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.37092351 |
| 32 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.35382238 |
| 33 | vitamin transmembrane transport (GO:0035461) | 4.34984960 |
| 34 | positive regulation of developmental pigmentation (GO:0048087) | 4.33489335 |
| 35 | ATP synthesis coupled proton transport (GO:0015986) | 4.31247069 |
| 36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.31247069 |
| 37 | sarcomere organization (GO:0045214) | 4.26539411 |
| 38 | sympathetic nervous system development (GO:0048485) | 4.25731220 |
| 39 | sulfate transmembrane transport (GO:1902358) | 4.25040236 |
| 40 | interferon-gamma secretion (GO:0072643) | 4.24465353 |
| 41 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.24023718 |
| 42 | SMAD protein complex assembly (GO:0007183) | 4.23956737 |
| 43 | regulation of hair follicle development (GO:0051797) | 4.21990208 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.20213461 |
| 45 | oxygen transport (GO:0015671) | 4.19549875 |
| 46 | neurotransmitter catabolic process (GO:0042135) | 4.16503059 |
| 47 | L-phenylalanine catabolic process (GO:0006559) | 4.12312743 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.12312743 |
| 49 | growth hormone secretion (GO:0030252) | 4.12031701 |
| 50 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.11171324 |
| 51 | cardiac myofibril assembly (GO:0055003) | 4.09449383 |
| 52 | tricarboxylic acid cycle (GO:0006099) | 4.08073429 |
| 53 | regulation of odontogenesis (GO:0042481) | 4.00347915 |
| 54 | regulation of actin filament-based movement (GO:1903115) | 3.97434237 |
| 55 | genitalia morphogenesis (GO:0035112) | 3.94980337 |
| 56 | ribonucleoprotein complex disassembly (GO:0032988) | 3.93323239 |
| 57 | cardiac muscle contraction (GO:0060048) | 3.90062107 |
| 58 | regulation of protein glycosylation (GO:0060049) | 3.89149152 |
| 59 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.86828435 |
| 60 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.86354515 |
| 61 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.85050557 |
| 62 | neurotransmitter biosynthetic process (GO:0042136) | 3.83607402 |
| 63 | cardiac muscle cell development (GO:0055013) | 3.82676838 |
| 64 | serotonin receptor signaling pathway (GO:0007210) | 3.81480648 |
| 65 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.73945219 |
| 66 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.71922393 |
| 67 | sulfate transport (GO:0008272) | 3.71740958 |
| 68 | ventricular cardiac muscle cell development (GO:0055015) | 3.68975457 |
| 69 | embryonic skeletal joint morphogenesis (GO:0060272) | 3.68412992 |
| 70 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.64151650 |
| 71 | myofibril assembly (GO:0030239) | 3.64065467 |
| 72 | piRNA metabolic process (GO:0034587) | 3.63710182 |
| 73 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.61417131 |
| 74 | cardiac cell development (GO:0055006) | 3.59452439 |
| 75 | regulation of membrane repolarization (GO:0060306) | 3.58102497 |
| 76 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.56113513 |
| 77 | lipopolysaccharide metabolic process (GO:0008653) | 3.54313149 |
| 78 | cell communication by electrical coupling (GO:0010644) | 3.51523772 |
| 79 | meiotic chromosome segregation (GO:0045132) | 3.50778808 |
| 80 | mesenchymal cell proliferation (GO:0010463) | 3.50476749 |
| 81 | relaxation of cardiac muscle (GO:0055119) | 3.50259292 |
| 82 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.45949153 |
| 83 | uterus development (GO:0060065) | 3.45018710 |
| 84 | lateral sprouting from an epithelium (GO:0060601) | 3.44996626 |
| 85 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.43712242 |
| 86 | creatine metabolic process (GO:0006600) | 3.42604597 |
| 87 | pancreas development (GO:0031016) | 3.41920395 |
| 88 | organelle disassembly (GO:1903008) | 3.38844840 |
| 89 | nodal signaling pathway (GO:0038092) | 3.37712291 |
| 90 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.37179283 |
| 91 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37140633 |
| 92 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.35787554 |
| 93 | striated muscle atrophy (GO:0014891) | 3.34410201 |
| 94 | negative regulation of muscle hypertrophy (GO:0014741) | 3.31844038 |
| 95 | L-phenylalanine metabolic process (GO:0006558) | 3.30560039 |
| 96 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.30560039 |
| 97 | gastrulation with mouth forming second (GO:0001702) | 3.28392444 |
| 98 | organ formation (GO:0048645) | 3.26633081 |
| 99 | tyrosine metabolic process (GO:0006570) | 3.25284926 |
| 100 | positive regulation of catecholamine secretion (GO:0033605) | 3.22540871 |
| 101 | regulation of keratinocyte proliferation (GO:0010837) | 3.22167093 |
| 102 | establishment of nucleus localization (GO:0040023) | 3.21243934 |
| 103 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.21168211 |
| 104 | carnitine shuttle (GO:0006853) | 3.19247285 |
| 105 | positive regulation of growth hormone secretion (GO:0060124) | 3.18414896 |
| 106 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 3.18327818 |
| 107 | succinate metabolic process (GO:0006105) | 3.17961167 |
| 108 | negative regulation of stem cell proliferation (GO:2000647) | 3.16967155 |
| 109 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 3.16921847 |
| 110 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.15746023 |
| 111 | plasma membrane repair (GO:0001778) | 3.15487938 |
| 112 | organ induction (GO:0001759) | 3.14741050 |
| 113 | somite rostral/caudal axis specification (GO:0032525) | 3.13083496 |
| 114 | oxidative phosphorylation (GO:0006119) | 3.12992853 |
| 115 | generation of neurons (GO:0048699) | 3.12692253 |
| 116 | regulation of striated muscle contraction (GO:0006942) | 3.12563004 |
| 117 | regulation of cardiac muscle contraction (GO:0055117) | 3.12483770 |
| 118 | regulation of hair cycle (GO:0042634) | 3.11438067 |
| 119 | synaptic transmission, cholinergic (GO:0007271) | 3.11146811 |
| 120 | short-term memory (GO:0007614) | 3.10917180 |
| 121 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.10903413 |
| 122 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.08280133 |
| 123 | keratinocyte development (GO:0003334) | 3.08219156 |
| 124 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.07482216 |
| 125 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.07482216 |
| 126 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.07109298 |
| 127 | cardiac conduction (GO:0061337) | 3.06856584 |
| 128 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05888286 |
| 129 | centriole replication (GO:0007099) | 3.05463996 |
| 130 | aromatic amino acid family catabolic process (GO:0009074) | 3.04426742 |
| 131 | detection of calcium ion (GO:0005513) | 3.04066723 |
| 132 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.03058364 |
| 133 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.00909723 |
| 134 | cartilage morphogenesis (GO:0060536) | 3.00389644 |
| 135 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.98626163 |
| 136 | muscle atrophy (GO:0014889) | 2.98195368 |
| 137 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.97778293 |
| 138 | response to nitric oxide (GO:0071731) | 2.97438681 |
| 139 | cardiac muscle cell action potential (GO:0086001) | 2.96425313 |
| 140 | regulation of activin receptor signaling pathway (GO:0032925) | 2.96343815 |
| 141 | skeletal muscle adaptation (GO:0043501) | 2.94423807 |
| 142 | muscle tissue morphogenesis (GO:0060415) | 2.94014261 |
| 143 | embryonic foregut morphogenesis (GO:0048617) | 2.93584442 |
| 144 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.92232964 |
| 145 | ATP biosynthetic process (GO:0006754) | 2.91092941 |
| 146 | heart trabecula formation (GO:0060347) | 2.90765213 |
| 147 | heart process (GO:0003015) | 2.89944580 |
| 148 | heart contraction (GO:0060047) | 2.89944580 |
| 149 | cellular ketone body metabolic process (GO:0046950) | 2.89920594 |
| 150 | 2-oxoglutarate metabolic process (GO:0006103) | 2.89583594 |
| 151 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.88441123 |
| 152 | striated muscle contraction (GO:0006941) | 2.87543453 |
| 153 | fatty acid transmembrane transport (GO:1902001) | 2.87052438 |
| 154 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.86288613 |
| 155 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.86288613 |
| 156 | negative regulation of BMP signaling pathway (GO:0030514) | 2.85914215 |
| 157 | branch elongation of an epithelium (GO:0060602) | 2.85566724 |
| 158 | nitric oxide biosynthetic process (GO:0006809) | 2.85403151 |
| 159 | neurofilament cytoskeleton organization (GO:0060052) | 2.85346368 |
| 160 | peristalsis (GO:0030432) | 2.83561016 |
| 161 | galactose catabolic process (GO:0019388) | 2.83553291 |
| 162 | postsynaptic membrane organization (GO:0001941) | 2.82631664 |
| 163 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.82049305 |
| 164 | hair follicle morphogenesis (GO:0031069) | 2.81564954 |
| 165 | regulation of the force of heart contraction (GO:0002026) | 2.80937290 |
| 166 | regulation of heart rate (GO:0002027) | 2.80577629 |
| 167 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.80476047 |
| 168 | SMAD protein signal transduction (GO:0060395) | 2.80236795 |
| 169 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.78775725 |
| 170 | galactose metabolic process (GO:0006012) | 2.77389824 |
| 171 | regulation of BMP signaling pathway (GO:0030510) | 2.76929283 |
| 172 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.76657237 |
| 173 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.76624326 |
| 174 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.76530672 |
| 175 | behavioral response to nicotine (GO:0035095) | 2.75089444 |
| 176 | cell migration in hindbrain (GO:0021535) | 2.74522832 |
| 177 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.74179193 |
| 178 | fatty acid homeostasis (GO:0055089) | 2.72530044 |
| 179 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.70028528 |
| 180 | morphogenesis of an epithelial fold (GO:0060571) | 2.67465738 |
| 181 | cytidine metabolic process (GO:0046087) | 2.66970204 |
| 182 | cytidine catabolic process (GO:0006216) | 2.66970204 |
| 183 | cytidine deamination (GO:0009972) | 2.66970204 |
| 184 | response to prostaglandin E (GO:0034695) | 2.66002837 |
| 185 | synaptic vesicle maturation (GO:0016188) | 2.65408473 |
| 186 | retinal ganglion cell axon guidance (GO:0031290) | 2.65156884 |
| 187 | regulation of interleukin-5 production (GO:0032674) | 2.64245864 |
| 188 | cellular response to epinephrine stimulus (GO:0071872) | 2.64131996 |
| 189 | kidney morphogenesis (GO:0060993) | 2.64007725 |
| 190 | neurotransmitter metabolic process (GO:0042133) | 2.63035737 |
| 191 | alkaloid metabolic process (GO:0009820) | 2.62775169 |
| 192 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.62636864 |
| 193 | mesenchymal cell differentiation (GO:0048762) | 2.62215151 |
| 194 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.62180328 |
| 195 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.61953081 |
| 196 | regulation of heart morphogenesis (GO:2000826) | 2.58641566 |
| 197 | tachykinin receptor signaling pathway (GO:0007217) | 2.58526672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.61539156 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.37743319 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.07593777 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.84447602 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.82960778 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.81615186 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.70969259 |
| 8 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.69619171 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.63729777 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.45579657 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43847193 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.34960111 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.31817375 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.13121578 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07559484 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.05853645 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.04871896 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.04232126 |
| 19 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.01024612 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.99607534 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.98632453 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.98632453 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90737231 |
| 24 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.88077057 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.87389037 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82190568 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.78555943 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.77067665 |
| 29 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76517246 |
| 30 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.76486878 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74863465 |
| 32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.74641217 |
| 33 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.74641217 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74002805 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66875953 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64178678 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.59529384 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59173823 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58832230 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57928152 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.57163492 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57047558 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55895955 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.55825937 |
| 45 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53891516 |
| 46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.53891516 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53457306 |
| 48 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52660387 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50966356 |
| 50 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48515962 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48482982 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47380152 |
| 53 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.45601246 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.45601246 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42663929 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41078253 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40436997 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39313534 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38588765 |
| 60 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.38585892 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38017828 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34478958 |
| 63 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33542011 |
| 64 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.31039150 |
| 65 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.30890510 |
| 66 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.30515253 |
| 67 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.30156678 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28782971 |
| 69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26959872 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.25546554 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25097239 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24418342 |
| 73 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.22577003 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21804624 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21662665 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21462749 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21412526 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20369276 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20074704 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20027001 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19640763 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19524585 |
| 83 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19349885 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16903848 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16682373 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15965714 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15644729 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15542785 |
| 89 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15322856 |
| 90 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.15181244 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15096143 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14482603 |
| 93 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.14427106 |
| 94 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13668789 |
| 95 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13117137 |
| 96 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13025165 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12296912 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11722153 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11576250 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.10748842 |
| 101 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10703862 |
| 102 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.10319690 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09559112 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09374479 |
| 105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09369580 |
| 106 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08483822 |
| 107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08072767 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07935862 |
| 109 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07584171 |
| 110 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06633310 |
| 111 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05481257 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05282362 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05282362 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04337422 |
| 115 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02217194 |
| 116 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01966986 |
| 117 | AR_19668381_ChIP-Seq_PC3_Human | 1.01440974 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01027998 |
| 119 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00798425 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00394824 |
| 121 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00198402 |
| 122 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99754835 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99619072 |
| 124 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99425845 |
| 125 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99020634 |
| 126 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98354694 |
| 127 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97790953 |
| 128 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97286235 |
| 129 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96820902 |
| 130 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96628656 |
| 131 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94217830 |
| 132 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93787128 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92973755 |
| 134 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92675579 |
| 135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91769558 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90902393 |
| 137 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90724453 |
| 138 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.89531412 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89084785 |
| 140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88956168 |
| 141 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88885475 |
| 142 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88306623 |
| 143 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88093955 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87557409 |
| 145 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86783363 |
| 146 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86488405 |
| 147 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.86469891 |
| 148 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.86081493 |
| 149 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86030457 |
| 150 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.85770858 |
| 151 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85100216 |
| 152 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84672704 |
| 153 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84410085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 6.18059025 |
| 2 | MP0003890_abnormal_embryonic-extraembry | 4.84459497 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.79039665 |
| 4 | MP0005171_absent_coat_pigmentation | 4.61235833 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.74177212 |
| 6 | MP0000751_myopathy | 3.68723575 |
| 7 | MP0006054_spinal_hemorrhage | 3.63079426 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.58996628 |
| 9 | MP0002254_reproductive_system_inflammat | 3.49101460 |
| 10 | MP0003646_muscle_fatigue | 3.18398659 |
| 11 | MP0000537_abnormal_urethra_morphology | 3.15519287 |
| 12 | MP0004510_myositis | 3.10933492 |
| 13 | MP0002653_abnormal_ependyma_morphology | 3.07235895 |
| 14 | MP0005330_cardiomyopathy | 3.04228352 |
| 15 | MP0000749_muscle_degeneration | 3.00907600 |
| 16 | MP0001348_abnormal_lacrimal_gland | 2.96178619 |
| 17 | MP0003879_abnormal_hair_cell | 2.83672668 |
| 18 | MP0004036_abnormal_muscle_relaxation | 2.79720120 |
| 19 | MP0002938_white_spotting | 2.78336522 |
| 20 | MP0002972_abnormal_cardiac_muscle | 2.68578259 |
| 21 | MP0004484_altered_response_of | 2.59010228 |
| 22 | MP0002876_abnormal_thyroid_physiology | 2.38407846 |
| 23 | MP0001485_abnormal_pinna_reflex | 2.33446583 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.22540739 |
| 25 | MP0003137_abnormal_impulse_conducting | 2.18603226 |
| 26 | MP0008775_abnormal_heart_ventricle | 2.14755023 |
| 27 | MP0001544_abnormal_cardiovascular_syste | 2.13204685 |
| 28 | MP0005385_cardiovascular_system_phenoty | 2.13204685 |
| 29 | MP0004270_analgesia | 2.09757741 |
| 30 | MP0004130_abnormal_muscle_cell | 2.09216971 |
| 31 | MP0001529_abnormal_vocalization | 2.07733914 |
| 32 | MP0001346_abnormal_lacrimal_gland | 2.04161948 |
| 33 | MP0004087_abnormal_muscle_fiber | 2.04009077 |
| 34 | MP0003937_abnormal_limbs/digits/tail_de | 2.01643325 |
| 35 | MP0000516_abnormal_urinary_system | 1.97698257 |
| 36 | MP0005367_renal/urinary_system_phenotyp | 1.97698257 |
| 37 | MP0003045_fibrosis | 1.96806798 |
| 38 | MP0002822_catalepsy | 1.96795566 |
| 39 | MP0005647_abnormal_sex_gland | 1.94159827 |
| 40 | MP0005187_abnormal_penis_morphology | 1.92237461 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.88044459 |
| 42 | MP0003221_abnormal_cardiomyocyte_apopto | 1.87450936 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.85483432 |
| 44 | MP0004085_abnormal_heartbeat | 1.82877316 |
| 45 | MP0004147_increased_porphyrin_level | 1.81519905 |
| 46 | MP0001984_abnormal_olfaction | 1.79767328 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.76182813 |
| 48 | MP0003828_pulmonary_edema | 1.67709748 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.65288061 |
| 50 | MP0009250_abnormal_appendicular_skeleto | 1.63218412 |
| 51 | MP0004381_abnormal_hair_follicle | 1.61810396 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.60096772 |
| 53 | MP0000685_abnormal_immune_system | 1.59911210 |
| 54 | MP0002269_muscular_atrophy | 1.56452838 |
| 55 | MP0002106_abnormal_muscle_physiology | 1.55844241 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.55684756 |
| 57 | MP0001286_abnormal_eye_development | 1.55079532 |
| 58 | MP0003119_abnormal_digestive_system | 1.51529300 |
| 59 | MP0003941_abnormal_skin_development | 1.51233656 |
| 60 | MP0002102_abnormal_ear_morphology | 1.50451031 |
| 61 | MP0000534_abnormal_ureter_morphology | 1.50429992 |
| 62 | MP0006138_congestive_heart_failure | 1.47298705 |
| 63 | MP0003385_abnormal_body_wall | 1.46822730 |
| 64 | MP0003880_abnormal_central_pattern | 1.42475055 |
| 65 | MP0002697_abnormal_eye_size | 1.41681200 |
| 66 | MP0009053_abnormal_anal_canal | 1.39160374 |
| 67 | MP0003938_abnormal_ear_development | 1.38398288 |
| 68 | MP0002160_abnormal_reproductive_system | 1.31154772 |
| 69 | MP0000759_abnormal_skeletal_muscle | 1.29933687 |
| 70 | MP0005646_abnormal_pituitary_gland | 1.24510084 |
| 71 | MP0005365_abnormal_bile_salt | 1.24376314 |
| 72 | MP0005248_abnormal_Harderian_gland | 1.23694275 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.22675154 |
| 74 | MP0000747_muscle_weakness | 1.22552185 |
| 75 | MP0003878_abnormal_ear_physiology | 1.21645315 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 1.21645315 |
| 77 | MP0005369_muscle_phenotype | 1.20825992 |
| 78 | MP0005085_abnormal_gallbladder_physiolo | 1.20666773 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.19408684 |
| 80 | MP0001324_abnormal_eye_pigmentation | 1.17979351 |
| 81 | MP0004859_abnormal_synaptic_plasticity | 1.17631179 |
| 82 | MP0000343_altered_response_to | 1.15985878 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.15502745 |
| 84 | MP0003942_abnormal_urinary_system | 1.14946113 |
| 85 | MP0000750_abnormal_muscle_regeneration | 1.14737159 |
| 86 | MP0002168_other_aberrant_phenotype | 1.13537875 |
| 87 | MP0000569_abnormal_digit_pigmentation | 1.11991245 |
| 88 | MP0002733_abnormal_thermal_nociception | 1.11831239 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 1.09725481 |
| 90 | MP0003195_calcinosis | 1.09656646 |
| 91 | MP0004858_abnormal_nervous_system | 1.09174298 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 1.07693103 |
| 93 | MP0005535_abnormal_body_temperature | 1.07186886 |
| 94 | MP0002272_abnormal_nervous_system | 1.07133624 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 1.06885256 |
| 96 | MP0003122_maternal_imprinting | 1.04567632 |
| 97 | MP0004742_abnormal_vestibular_system | 1.04187216 |
| 98 | MP0001963_abnormal_hearing_physiology | 1.02321175 |
| 99 | MP0003315_abnormal_perineum_morphology | 1.01656683 |
| 100 | MP0005165_increased_susceptibility_to | 0.99814395 |
| 101 | MP0002184_abnormal_innervation | 0.99446482 |
| 102 | MP0000778_abnormal_nervous_system | 0.99170264 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.99030327 |
| 104 | MP0000427_abnormal_hair_cycle | 0.98071461 |
| 105 | MP0003959_abnormal_lean_body | 0.96318424 |
| 106 | MP0002127_abnormal_cardiovascular_syste | 0.93595295 |
| 107 | MP0000647_abnormal_sebaceous_gland | 0.93249404 |
| 108 | MP0001501_abnormal_sleep_pattern | 0.90098504 |
| 109 | MP0000383_abnormal_hair_follicle | 0.87605708 |
| 110 | MP0003943_abnormal_hepatobiliary_system | 0.86317540 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.85739732 |
| 112 | MP0005332_abnormal_amino_acid | 0.84417572 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.82798335 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.82184439 |
| 115 | MP0001293_anophthalmia | 0.80749666 |
| 116 | MP0003935_abnormal_craniofacial_develop | 0.80584060 |
| 117 | MP0002282_abnormal_trachea_morphology | 0.80450995 |
| 118 | MP0005266_abnormal_metabolism | 0.80246703 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.80231327 |
| 120 | MP0008874_decreased_physiological_sensi | 0.80174709 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.80139474 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.80015192 |
| 123 | MP0000432_abnormal_head_morphology | 0.79891592 |
| 124 | MP0002557_abnormal_social/conspecific_i | 0.79141382 |
| 125 | MP0000428_abnormal_craniofacial_morphol | 0.78383786 |
| 126 | MP0004885_abnormal_endolymph | 0.78147287 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.77254476 |
| 128 | MP0001440_abnormal_grooming_behavior | 0.77140140 |
| 129 | MP0002095_abnormal_skin_pigmentation | 0.76823453 |
| 130 | MP0002233_abnormal_nose_morphology | 0.76756131 |
| 131 | MP0009697_abnormal_copulation | 0.76231417 |
| 132 | MP0000049_abnormal_middle_ear | 0.75780435 |
| 133 | MP0001970_abnormal_pain_threshold | 0.75628489 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.75048563 |
| 135 | MP0000026_abnormal_inner_ear | 0.74842591 |
| 136 | MP0006035_abnormal_mitochondrial_morpho | 0.73544519 |
| 137 | MP0002752_abnormal_somatic_nervous | 0.73377746 |
| 138 | MP0002928_abnormal_bile_duct | 0.72566596 |
| 139 | MP0009780_abnormal_chondrocyte_physiolo | 0.71676387 |
| 140 | MP0003121_genomic_imprinting | 0.71346401 |
| 141 | MP0010678_abnormal_skin_adnexa | 0.71153969 |
| 142 | MP0002108_abnormal_muscle_morphology | 0.70913688 |
| 143 | MP0001486_abnormal_startle_reflex | 0.70853773 |
| 144 | MP0002971_abnormal_brown_adipose | 0.70851776 |
| 145 | MP0005195_abnormal_posterior_eye | 0.70570401 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.69863448 |
| 147 | MP0002084_abnormal_developmental_patter | 0.69685271 |
| 148 | MP0004142_abnormal_muscle_tone | 0.69508042 |
| 149 | MP0004043_abnormal_pH_regulation | 0.68566079 |
| 150 | MP0004924_abnormal_behavior | 0.68524434 |
| 151 | MP0005386_behavior/neurological_phenoty | 0.68524434 |
| 152 | MP0004133_heterotaxia | 0.66779645 |
| 153 | MP0003635_abnormal_synaptic_transmissio | 0.66388002 |
| 154 | MP0008569_lethality_at_weaning | 0.66319968 |
| 155 | MP0002118_abnormal_lipid_homeostasis | 0.65693666 |
| 156 | MP0005670_abnormal_white_adipose | 0.65507285 |
| 157 | MP0002229_neurodegeneration | 0.64484590 |
| 158 | MP0002111_abnormal_tail_morphology | 0.62608664 |
| 159 | MP0001299_abnormal_eye_distance/ | 0.62247620 |
| 160 | MP0002751_abnormal_autonomic_nervous | 0.61968772 |
| 161 | MP0003806_abnormal_nucleotide_metabolis | 0.61805171 |
| 162 | MP0005310_abnormal_salivary_gland | 0.61757059 |
| 163 | MP0010030_abnormal_orbit_morphology | 0.61665308 |
| 164 | MP0006082_CNS_inflammation | 0.61282565 |
| 165 | MP0002067_abnormal_sensory_capabilities | 0.60614465 |
| 166 | MP0003861_abnormal_nervous_system | 0.60430405 |
| 167 | MP0000955_abnormal_spinal_cord | 0.60123987 |
| 168 | MP0005334_abnormal_fat_pad | 0.59945839 |
| 169 | MP0001873_stomach_inflammation | 0.59527438 |
| 170 | MP0010386_abnormal_urinary_bladder | 0.58991456 |
| 171 | MP0009745_abnormal_behavioral_response | 0.58958445 |
| 172 | MP0005395_other_phenotype | 0.58813855 |
| 173 | MP0002882_abnormal_neuron_morphology | 0.56994531 |
| 174 | MP0000462_abnormal_digestive_system | 0.56214986 |
| 175 | MP0003252_abnormal_bile_duct | 0.56130985 |
| 176 | MP0002572_abnormal_emotion/affect_behav | 0.56115248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ventricular tachycardia (HP:0004756) | 5.65041052 |
| 2 | Sudden death (HP:0001699) | 5.52906813 |
| 3 | Amelogenesis imperfecta (HP:0000705) | 5.33007481 |
| 4 | Acanthocytosis (HP:0001927) | 5.01242148 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 5.01196707 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.95151979 |
| 7 | Morphological abnormality of the middle ear (HP:0008609) | 4.81894410 |
| 8 | Palpitations (HP:0001962) | 4.73413196 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.64343305 |
| 10 | Atrial fibrillation (HP:0005110) | 4.61402804 |
| 11 | Bundle branch block (HP:0011710) | 4.52818352 |
| 12 | Acute encephalopathy (HP:0006846) | 4.48353467 |
| 13 | Progressive macrocephaly (HP:0004481) | 4.36465335 |
| 14 | Abnormality of the vocal cords (HP:0008777) | 4.33962940 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.33638258 |
| 16 | Proximal tubulopathy (HP:0000114) | 4.29943262 |
| 17 | Supraventricular tachycardia (HP:0004755) | 4.14950780 |
| 18 | Congenital malformation of the right heart (HP:0011723) | 4.06556114 |
| 19 | Double outlet right ventricle (HP:0001719) | 4.06556114 |
| 20 | Cerebral edema (HP:0002181) | 4.04560997 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.02717502 |
| 22 | Syncope (HP:0001279) | 4.01583488 |
| 23 | Disproportionate short-trunk short stature (HP:0003521) | 3.99512542 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 3.98746157 |
| 25 | Pheochromocytoma (HP:0002666) | 3.82519572 |
| 26 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.80765442 |
| 27 | Volvulus (HP:0002580) | 3.74908746 |
| 28 | Lipoatrophy (HP:0100578) | 3.70512311 |
| 29 | Prolonged QT interval (HP:0001657) | 3.57240221 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.53809883 |
| 31 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.53473796 |
| 32 | Neuroendocrine neoplasm (HP:0100634) | 3.46492315 |
| 33 | Mitochondrial inheritance (HP:0001427) | 3.46287713 |
| 34 | Enlarged kidneys (HP:0000105) | 3.44268540 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 3.43024072 |
| 36 | Heart block (HP:0012722) | 3.38304555 |
| 37 | Hepatic necrosis (HP:0002605) | 3.33481937 |
| 38 | Exercise-induced myalgia (HP:0003738) | 3.29559554 |
| 39 | Myoglobinuria (HP:0002913) | 3.26080964 |
| 40 | Myelomeningocele (HP:0002475) | 3.23642253 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 3.19104589 |
| 42 | Dilated cardiomyopathy (HP:0001644) | 3.17771320 |
| 43 | Muscle fiber splitting (HP:0003555) | 3.17342728 |
| 44 | Ventricular arrhythmia (HP:0004308) | 3.09237984 |
| 45 | Colon cancer (HP:0003003) | 3.06307966 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 3.03414086 |
| 47 | Increased CSF lactate (HP:0002490) | 3.02727782 |
| 48 | Asymmetric septal hypertrophy (HP:0001670) | 3.01990732 |
| 49 | Hypoglycemic coma (HP:0001325) | 3.01659213 |
| 50 | Rectal prolapse (HP:0002035) | 3.01566583 |
| 51 | Myokymia (HP:0002411) | 3.01517950 |
| 52 | Dialeptic seizures (HP:0011146) | 3.00096633 |
| 53 | Ketoacidosis (HP:0001993) | 2.98351118 |
| 54 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.98344106 |
| 55 | Cervical subluxation (HP:0003308) | 2.98166331 |
| 56 | Vertebral arch anomaly (HP:0008438) | 2.95221137 |
| 57 | Anophthalmia (HP:0000528) | 2.92917734 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.89442724 |
| 59 | Proximal amyotrophy (HP:0007126) | 2.88264794 |
| 60 | Abnormality of the renal cortex (HP:0011035) | 2.88243584 |
| 61 | Hepatocellular necrosis (HP:0001404) | 2.86078237 |
| 62 | EMG: myopathic abnormalities (HP:0003458) | 2.82178655 |
| 63 | Pancreatic cysts (HP:0001737) | 2.80397952 |
| 64 | Bifid tongue (HP:0010297) | 2.79824839 |
| 65 | Cutaneous finger syndactyly (HP:0010554) | 2.78548183 |
| 66 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.72138028 |
| 67 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.71967887 |
| 68 | Parakeratosis (HP:0001036) | 2.71594698 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.69593221 |
| 70 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.66810530 |
| 71 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.66250344 |
| 72 | Respiratory failure (HP:0002878) | 2.65151956 |
| 73 | Bilateral microphthalmos (HP:0007633) | 2.65025357 |
| 74 | Intestinal atresia (HP:0011100) | 2.64849020 |
| 75 | Atrioventricular block (HP:0001678) | 2.59061555 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 2.58963253 |
| 77 | Conjunctival hamartoma (HP:0100780) | 2.57821846 |
| 78 | Nephronophthisis (HP:0000090) | 2.57707928 |
| 79 | Myotonia (HP:0002486) | 2.52518682 |
| 80 | Abnormal tarsal ossification (HP:0008369) | 2.51962894 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.51929977 |
| 82 | Exercise intolerance (HP:0003546) | 2.51608171 |
| 83 | Hypothermia (HP:0002045) | 2.50634627 |
| 84 | Hypercortisolism (HP:0001578) | 2.50442790 |
| 85 | Lactic acidosis (HP:0003128) | 2.46510104 |
| 86 | Synostosis of carpal bones (HP:0005048) | 2.44024385 |
| 87 | Difficulty walking (HP:0002355) | 2.42925491 |
| 88 | Focal seizures (HP:0007359) | 2.42395458 |
| 89 | Abnormality of the wing of the ilium (HP:0011867) | 2.42050056 |
| 90 | Long clavicles (HP:0000890) | 2.41991046 |
| 91 | Optic disc pallor (HP:0000543) | 2.39590641 |
| 92 | Proximal placement of thumb (HP:0009623) | 2.38293297 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.38254692 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 2.38254692 |
| 95 | Hypoplastic iliac wings (HP:0002866) | 2.37211166 |
| 96 | Thyroid-stimulating hormone excess (HP:0002925) | 2.36983677 |
| 97 | High anterior hairline (HP:0009890) | 2.36845413 |
| 98 | Bicornuate uterus (HP:0000813) | 2.36228239 |
| 99 | Cortical dysplasia (HP:0002539) | 2.36012822 |
| 100 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34759055 |
| 101 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34759055 |
| 102 | Abnormal EKG (HP:0003115) | 2.32781041 |
| 103 | Left ventricular hypertrophy (HP:0001712) | 2.32354030 |
| 104 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32262500 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 2.32146819 |
| 106 | Action tremor (HP:0002345) | 2.31488262 |
| 107 | Anencephaly (HP:0002323) | 2.30740824 |
| 108 | Abnormality of the pubic bones (HP:0003172) | 2.30738950 |
| 109 | Aplastic anemia (HP:0001915) | 2.30265639 |
| 110 | Cutaneous syndactyly (HP:0012725) | 2.27584705 |
| 111 | Ketosis (HP:0001946) | 2.26789504 |
| 112 | Abnormality of the ischium (HP:0003174) | 2.21999954 |
| 113 | Genital tract atresia (HP:0001827) | 2.19879272 |
| 114 | Short 1st metacarpal (HP:0010034) | 2.18500247 |
| 115 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.18500247 |
| 116 | Hyperglycemia (HP:0003074) | 2.18095898 |
| 117 | Foot dorsiflexor weakness (HP:0009027) | 2.17887479 |
| 118 | IgM deficiency (HP:0002850) | 2.17883031 |
| 119 | Asymmetry of the thorax (HP:0001555) | 2.17636247 |
| 120 | 2-3 toe syndactyly (HP:0004691) | 2.16919571 |
| 121 | Hypoplasia of the odontoid process (HP:0003311) | 2.16446533 |
| 122 | Autoamputation (HP:0001218) | 2.14503661 |
| 123 | Hypoplastic ischia (HP:0003175) | 2.13384053 |
| 124 | Ulnar claw (HP:0001178) | 2.13339214 |
| 125 | Vaginal atresia (HP:0000148) | 2.11467004 |
| 126 | Deviation of the thumb (HP:0009603) | 2.11277407 |
| 127 | Steppage gait (HP:0003376) | 2.09684299 |
| 128 | Poikilocytosis (HP:0004447) | 2.08766627 |
| 129 | Esophageal varix (HP:0002040) | 2.08723997 |
| 130 | Leukodystrophy (HP:0002415) | 2.08214729 |
| 131 | Ulnar deviation of the wrist (HP:0003049) | 2.07884030 |
| 132 | Sudden cardiac death (HP:0001645) | 2.07869638 |
| 133 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.07005900 |
| 134 | Tubulointerstitial fibrosis (HP:0005576) | 2.06987909 |
| 135 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06088930 |
| 136 | Keratoconjunctivitis (HP:0001096) | 2.05202013 |
| 137 | Hematochezia (HP:0002573) | 2.02018193 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01628148 |
| 139 | Cerebral hemorrhage (HP:0001342) | 2.01047517 |
| 140 | Potter facies (HP:0002009) | 2.00396399 |
| 141 | Facial shape deformation (HP:0011334) | 2.00396399 |
| 142 | Rhabdomyolysis (HP:0003201) | 2.00375376 |
| 143 | Generalized myoclonic seizures (HP:0002123) | 2.00200036 |
| 144 | Tinnitus (HP:0000360) | 2.00112154 |
| 145 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.00014983 |
| 146 | Lethargy (HP:0001254) | 1.98981247 |
| 147 | Abnormality of the foot musculature (HP:0001436) | 1.98503139 |
| 148 | Severe Myopia (HP:0011003) | 1.98280227 |
| 149 | Renal cortical cysts (HP:0000803) | 1.97012067 |
| 150 | Palmoplantar keratoderma (HP:0000982) | 1.96830173 |
| 151 | Difficulty running (HP:0009046) | 1.95854582 |
| 152 | Generalized aminoaciduria (HP:0002909) | 1.95322052 |
| 153 | Renal hypoplasia (HP:0000089) | 1.94705203 |
| 154 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.94051520 |
| 155 | Xerostomia (HP:0000217) | 1.93530251 |
| 156 | Bell-shaped thorax (HP:0001591) | 1.92840324 |
| 157 | Subaortic stenosis (HP:0001682) | 1.89398954 |
| 158 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.89398954 |
| 159 | Abnormality of urine glucose concentration (HP:0011016) | 1.89392094 |
| 160 | Glycosuria (HP:0003076) | 1.89392094 |
| 161 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.89354994 |
| 162 | Hyperammonemia (HP:0001987) | 1.89350476 |
| 163 | Areflexia of lower limbs (HP:0002522) | 1.89290431 |
| 164 | Abnormality of the 1st metacarpal (HP:0010009) | 1.88672247 |
| 165 | Long nose (HP:0003189) | 1.88631894 |
| 166 | Cupped ear (HP:0000378) | 1.88163859 |
| 167 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86787097 |
| 168 | Vacuolated lymphocytes (HP:0001922) | 1.86010147 |
| 169 | Diastasis recti (HP:0001540) | 1.85951203 |
| 170 | Erythroderma (HP:0001019) | 1.85670266 |
| 171 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.85462780 |
| 172 | Termporal pattern (HP:0011008) | 1.84304958 |
| 173 | Insidious onset (HP:0003587) | 1.84304958 |
| 174 | Cholelithiasis (HP:0001081) | 1.83297472 |
| 175 | Neoplasm of the adrenal gland (HP:0100631) | 1.83033591 |
| 176 | Onion bulb formation (HP:0003383) | 1.81974456 |
| 177 | Muscle stiffness (HP:0003552) | 1.79017638 |
| 178 | Absent eyebrow (HP:0002223) | 1.78943152 |
| 179 | Focal motor seizures (HP:0011153) | 1.78063604 |
| 180 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.77227986 |
| 181 | Abnormal foot bone ossification (HP:0010675) | 1.76865851 |
| 182 | Tarsal synostosis (HP:0008368) | 1.74104542 |
| 183 | Abnormality of the nasal septum (HP:0000419) | 1.73656754 |
| 184 | Short phalanx of the thumb (HP:0009660) | 1.73206732 |
| 185 | Neoplasm of the small intestine (HP:0100833) | 1.72694912 |
| 186 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.70757387 |
| 187 | Tracheal stenosis (HP:0002777) | 1.70735258 |
| 188 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.68431792 |
| 189 | Small epiphyses (HP:0010585) | 1.67741201 |
| 190 | Gastrointestinal atresia (HP:0002589) | 1.64724042 |
| 191 | Synostosis involving bones of the feet (HP:0009140) | 1.64172194 |
| 192 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.64172194 |
| 193 | Abnormality of the odontoid process (HP:0003310) | 1.63050754 |
| 194 | Cerebellar dysplasia (HP:0007033) | 1.61743597 |
| 195 | Scapular winging (HP:0003691) | 1.61622756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 7.76181188 |
| 2 | TRIM28 | 5.02896974 |
| 3 | LMTK2 | 3.46128509 |
| 4 | TTN | 3.17320177 |
| 5 | ACVR1B | 2.99177048 |
| 6 | GRK7 | 2.89228818 |
| 7 | FRK | 2.82654809 |
| 8 | WNK4 | 2.75193583 |
| 9 | MUSK | 2.74037441 |
| 10 | STK39 | 2.69068098 |
| 11 | SIK3 | 2.67015294 |
| 12 | PHKG2 | 2.55206221 |
| 13 | PHKG1 | 2.55206221 |
| 14 | NTRK1 | 2.55186467 |
| 15 | EPHA3 | 2.54184511 |
| 16 | BCR | 2.46912939 |
| 17 | PDK4 | 2.46716242 |
| 18 | PDK3 | 2.46716242 |
| 19 | MYLK | 2.38572518 |
| 20 | BMPR1B | 2.36521106 |
| 21 | BCKDK | 2.12306996 |
| 22 | PLK4 | 2.06740024 |
| 23 | OBSCN | 1.98299946 |
| 24 | WNK1 | 1.93598109 |
| 25 | ZAK | 1.92220831 |
| 26 | EPHB1 | 1.81279109 |
| 27 | TGFBR1 | 1.77102007 |
| 28 | PINK1 | 1.75688734 |
| 29 | PRKD3 | 1.75413421 |
| 30 | TNIK | 1.74263353 |
| 31 | OXSR1 | 1.60164782 |
| 32 | NME2 | 1.54831136 |
| 33 | DDR2 | 1.52552698 |
| 34 | NTRK3 | 1.51186144 |
| 35 | INSRR | 1.49278013 |
| 36 | STK3 | 1.43998783 |
| 37 | MKNK2 | 1.38914384 |
| 38 | PAK3 | 1.35736379 |
| 39 | TRPM7 | 1.34277222 |
| 40 | EPHA4 | 1.34045172 |
| 41 | FGFR2 | 1.33880534 |
| 42 | FGFR4 | 1.31018541 |
| 43 | TAF1 | 1.29876116 |
| 44 | PKN2 | 1.27807484 |
| 45 | CAMK2D | 1.25904362 |
| 46 | NLK | 1.23181524 |
| 47 | SCYL2 | 1.21383323 |
| 48 | PDK2 | 1.20258373 |
| 49 | PIK3CG | 1.10924399 |
| 50 | GRK5 | 1.08705813 |
| 51 | MAP2K2 | 1.08587929 |
| 52 | PIK3CA | 1.06932912 |
| 53 | STK24 | 1.05692557 |
| 54 | CDC42BPA | 1.01659253 |
| 55 | NEK2 | 0.98779482 |
| 56 | DMPK | 0.97696803 |
| 57 | MAP3K14 | 0.95555459 |
| 58 | PRKCE | 0.95182870 |
| 59 | MINK1 | 0.93393454 |
| 60 | TLK1 | 0.92302123 |
| 61 | LRRK2 | 0.91943666 |
| 62 | MKNK1 | 0.88348222 |
| 63 | ERBB3 | 0.87382669 |
| 64 | CLK1 | 0.87287738 |
| 65 | CSNK1G3 | 0.82612728 |
| 66 | CAMK2G | 0.81434730 |
| 67 | WEE1 | 0.81351929 |
| 68 | CDK19 | 0.80303673 |
| 69 | JAK1 | 0.79858223 |
| 70 | CASK | 0.77826136 |
| 71 | CAMK2A | 0.77609911 |
| 72 | MAP4K2 | 0.75713868 |
| 73 | ROCK2 | 0.73561394 |
| 74 | MAP3K7 | 0.73515060 |
| 75 | PRKCQ | 0.72181983 |
| 76 | PKN1 | 0.71082184 |
| 77 | LATS2 | 0.70860126 |
| 78 | EIF2AK3 | 0.70821997 |
| 79 | DYRK1B | 0.69465378 |
| 80 | NEK9 | 0.69412252 |
| 81 | ROCK1 | 0.69394390 |
| 82 | KSR2 | 0.68307901 |
| 83 | IRAK4 | 0.68291367 |
| 84 | CSNK1G2 | 0.68251549 |
| 85 | NEK1 | 0.66523561 |
| 86 | UHMK1 | 0.66317345 |
| 87 | ITK | 0.64261004 |
| 88 | WNK3 | 0.64211937 |
| 89 | ADRBK1 | 0.63847205 |
| 90 | FLT3 | 0.63090729 |
| 91 | FGFR3 | 0.62416215 |
| 92 | CSNK1G1 | 0.62185262 |
| 93 | MAPKAPK5 | 0.61307794 |
| 94 | PRKD1 | 0.61298437 |
| 95 | JAK2 | 0.59180211 |
| 96 | TTK | 0.59134889 |
| 97 | PRKACB | 0.59039664 |
| 98 | STK38L | 0.58378652 |
| 99 | ERBB2 | 0.56950579 |
| 100 | SGK223 | 0.56780649 |
| 101 | SGK494 | 0.56780649 |
| 102 | LIMK1 | 0.56433124 |
| 103 | MAP2K1 | 0.55962882 |
| 104 | MAP3K2 | 0.55309299 |
| 105 | PRKAA2 | 0.55245088 |
| 106 | ADRBK2 | 0.54844700 |
| 107 | RET | 0.54739531 |
| 108 | MATK | 0.54502876 |
| 109 | TIE1 | 0.54123423 |
| 110 | TGFBR2 | 0.53107243 |
| 111 | PRKCI | 0.52448309 |
| 112 | PDPK1 | 0.52347289 |
| 113 | FER | 0.51582275 |
| 114 | PASK | 0.49836919 |
| 115 | STK11 | 0.49519354 |
| 116 | ARAF | 0.49368068 |
| 117 | MAP3K9 | 0.49357542 |
| 118 | PDK1 | 0.49136599 |
| 119 | MELK | 0.48350202 |
| 120 | PLK3 | 0.48113536 |
| 121 | CAMK1 | 0.47368973 |
| 122 | PRKACA | 0.47242979 |
| 123 | PAK6 | 0.46988490 |
| 124 | MAP2K7 | 0.46820010 |
| 125 | BMPR2 | 0.46675220 |
| 126 | MAP3K12 | 0.45857124 |
| 127 | MAP2K4 | 0.45695593 |
| 128 | PRKACG | 0.45350189 |
| 129 | CDK3 | 0.44194734 |
| 130 | CSNK1A1L | 0.43795045 |
| 131 | PRKCH | 0.43606195 |
| 132 | EPHB2 | 0.43217869 |
| 133 | STK38 | 0.42711825 |
| 134 | CDK5 | 0.40955102 |
| 135 | SGK2 | 0.40073115 |
| 136 | KSR1 | 0.39332485 |
| 137 | SYK | 0.38849909 |
| 138 | PLK1 | 0.37956224 |
| 139 | MAP3K4 | 0.37356704 |
| 140 | PRKCD | 0.36553794 |
| 141 | PRKCG | 0.35890260 |
| 142 | PLK2 | 0.35648564 |
| 143 | PRKAA1 | 0.35549729 |
| 144 | MAP3K6 | 0.33855047 |
| 145 | BRSK2 | 0.32442550 |
| 146 | ILK | 0.30421380 |
| 147 | CDK8 | 0.27203633 |
| 148 | MARK1 | 0.26191483 |
| 149 | SRPK1 | 0.26154034 |
| 150 | STK10 | 0.24176570 |
| 151 | NME1 | 0.24022862 |
| 152 | CSNK1D | 0.22911562 |
| 153 | PNCK | 0.19321293 |
| 154 | TEC | 0.12140798 |
| 155 | GRK1 | 0.12125886 |
| 156 | FGFR1 | 0.11310604 |
| 157 | AKT2 | 0.10530785 |
| 158 | PDGFRA | 0.10029840 |
| 159 | CHEK2 | 0.07429876 |
| 160 | ABL1 | 0.06119910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.22462149 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.93866394 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.72849078 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.72488600 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.58982341 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 3.48612441 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.10078025 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.82971899 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.75654991 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.59652508 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.37132501 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.35934347 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34544391 |
| 14 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.28935052 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27432393 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 2.22045775 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.19427692 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.19317897 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.18380823 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.11983560 |
| 21 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.02861977 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.01413504 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.00407333 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.92900086 |
| 25 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.78646817 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.78029149 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77145257 |
| 28 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.76491574 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67775440 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.60603162 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.59118865 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57341829 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55240314 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49239137 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49146339 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45565078 |
| 37 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.42003618 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.38289993 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.37475558 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29921948 |
| 41 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26552036 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.25817189 |
| 43 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.25521812 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23666296 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16448322 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13602379 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12187048 |
| 48 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.12163682 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10593023 |
| 50 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08202697 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04695614 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 1.04658363 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03385667 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02725790 |
| 55 | Adherens junction_Homo sapiens_hsa04520 | 1.01999552 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99484394 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91957957 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89597221 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88295715 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.87546942 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86194630 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.85308989 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84758404 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82991757 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82777085 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78768433 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78748018 |
| 68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76732699 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76076122 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75851425 |
| 71 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.75672724 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72096835 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70030939 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68970736 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67849868 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66465186 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66308705 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63880932 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63450090 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62444561 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60681251 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60343495 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.60166739 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57681822 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.56827494 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55655925 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53985977 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53969946 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53765489 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53066376 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.52723975 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52495594 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51673023 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.51584349 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51189148 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.51011818 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.50400595 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48668157 |
| 99 | Taste transduction_Homo sapiens_hsa04742 | 0.48468447 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.48376166 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48070581 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47395471 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46706237 |
| 104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46330627 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45236574 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44756178 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44275018 |
| 108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44044447 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43425982 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42409479 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42348896 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42211101 |
| 113 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41745365 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39840283 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39830452 |
| 116 | Asthma_Homo sapiens_hsa05310 | 0.39513470 |
| 117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38895149 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38595709 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38313241 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38183241 |
| 121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37580311 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37396215 |
| 123 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37250466 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.37248913 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36988181 |
| 126 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36812997 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36008390 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35324095 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34815467 |
| 130 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34103957 |
| 131 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33945733 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33847161 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33348837 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | 0.32697349 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32625320 |
| 136 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32349193 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31880394 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31484462 |
| 139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30511357 |
| 140 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30402572 |
| 141 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30027704 |
| 142 | Morphine addiction_Homo sapiens_hsa05032 | 0.29894548 |
| 143 | Homologous recombination_Homo sapiens_hsa03440 | 0.27900562 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27871911 |
| 145 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26778559 |
| 146 | Gap junction_Homo sapiens_hsa04540 | 0.26428794 |
| 147 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26363764 |
| 148 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25487019 |
| 149 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22459671 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17842601 |
| 151 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.17633400 |
| 152 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16963375 |
| 153 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16807985 |
| 154 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16196948 |

